Peripheral T-cell lymphoma presenting as myelofibrosis with the expression of basic fibroblast growth factor

被引:6
作者
Kikukawa, Masayuki [1 ]
Umahara, Takahiko
Kikawada, Masayuki
Kanaya, Kiyoshi [1 ]
Sakurai, Hirofumi
Shin, Kouichi
Mori, Mayumi
Iwamoto, Toshihiko
机构
[1] Tokyo Med Univ, Dept Geriatr Med, Hachioji Med Ctr, Shinjuku Ku, Tokyo 1600023, Japan
关键词
basic fibroblast growth factor; cytokines; myelofibrosis; peripheral T-cell lymphoma; BONE-MARROW FIBROSIS; LEUKEMIA;
D O I
10.1111/j.1447-0594.2009.00556.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Myelofibrosis is often observed in chronic myeloproliferative disorders (CMPD), but non-Hodgkin's lymphoma with diffuse myelofibrosis is rare. We describe an elderly case with peripheral T-cell lymphoma-unspecified (PTCL) presenting as diffuse myelofibrosis. Bone marrow biopsy revealed infiltration of atypical lymphocytes and diffuse myelofibrosis without any increase in megakaryocytes. To discuss the pathogenesis of fibrosis, we examined cytokines relative to fibrosis using immunostaining. The expression of basic fibroblast growth factor (bFGF) was diffusely detected in the area of extracellular matrix of bone marrow. In addition, in situ hybridization revealed that infiltrating lymphoma cells expressed bFGF mRNA. Basic FGF, originally identified based on its mitogenicity for fibroblasts, has multiple potential, influencing neoangiogenesis, bone marrow fibrosis and the proliferation of tumor cells. Basic FGF might play an important role in the pathogenesis of myelofibrosis in the present case.
引用
收藏
页码:395 / 398
页数:4
相关论文
共 18 条
  • [1] Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-β
    Abe, Y
    Ohshima, K
    Shiratsuchi, M
    Honda, K
    Nishimura, J
    Nawata, H
    Muta, K
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (03) : 210 - 212
  • [2] The role of autocrine FGF-2 in the distinctive bone marrow fibrosis of hairy-cell leukemia (HCL)
    Aziz, KA
    Till, KJ
    Chen, HJ
    Slupsky, JR
    Campbell, F
    Cawley, JC
    Zuzel, M
    [J]. BLOOD, 2003, 102 (03) : 1051 - 1056
  • [3] Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma
    Bisping, G
    Leo, R
    Wenning, D
    Dankbar, B
    Padró, T
    Kropff, M
    Scheffold, C
    Kröger, M
    Mesters, RM
    Berdel, WE
    Kienast, J
    [J]. BLOOD, 2003, 101 (07) : 2775 - 2783
  • [4] BURTHEM J, 1994, BLOOD, V83, P497
  • [5] HEPARIN AND HEPARAN-SULFATE INCREASE THE RADIUS OF DIFFUSION AND ACTION OF BASIC FIBROBLAST GROWTH-FACTOR
    FLAUMENHAFT, R
    MOSCATELLI, D
    RIFKIN, DB
    [J]. JOURNAL OF CELL BIOLOGY, 1990, 111 (04) : 1651 - 1659
  • [6] Gisselbrecht C, 1998, BLOOD, V92, P76
  • [7] Pure red cell aplasia and myelofibrosis in B-cell neoplasm
    Hatta, Y
    Kura, Y
    Yano, T
    Ushiyama, H
    Sugitani, M
    Okano, T
    Ishizuka, H
    Sawada, U
    Adachi, Y
    Horie, T
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2005, 33 (04) : 460 - 466
  • [8] Kasahara K, 1998, Rinsho Ketsueki, V39, P1180
  • [9] MACARTHY DM, 1985, BRIT J HAEMATOL, V59, P1
  • [10] Basic fibroblast growth factor and fibrosis in Hodgkin's disease
    Ohshima, K
    Sugihara, M
    Suzumiya, J
    Haraoka, S
    Kanda, M
    Shimazaki, K
    Katoh, K
    Kumagawa, M
    Kikuchi, M
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1999, 195 (03) : 149 - 155